10X Capital Venture Acquisition Corp. III
VCXBDelisted Jul 26, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001848948
10X Capital Venture Acquisition Corp. III was delisted on Jul 26, 2024; its insiders filed their last Form 4 on Mar 11, 2022; 11 institutions reported holding it in 13F filings for Q2 2024, worth $21.4M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding 10X Capital Venture Acquisition Corp. III changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 52 | 1 | 17 | −34 |
| Shares | 20.6M | 400.0K | 4.00M | −16.2M (−80.2%) |
| Value | $205.6M | $3.91M | $41.2M | −$160.4M (−79.6%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cubist Systematic Strategies, LLC | 198,676 | $2.06M | 0.02% |
| Rpo LLC | 192,878 | $1.99M | 0.61% |
| Deutsche Bank AG | 714 | $7.32K | 0.00% |
| Clear Street LLC | 308 | $3.19K | 0.00% |
Sold out (38)
Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (1)
Institutions that held 10X Capital Venture Acquisition Corp. III at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Kepos Capital LP | 400,000 | $3.91M |